25-OH Vitamin D: How to Interpret Your Result

What Does 25-OH Vitamin D Actually Measure?

The 25-hydroxyvitamin D test measures the total concentration of calcidiol in your blood, the form your liver produces after converting vitamin D from sunlight, food, or supplements. This is not the active hormone. Your kidneys convert 25-OH vitamin D into 1,25-dihydroxyvitamin D (calcitriol), which does the biological work. Clinicians test 25-OH vitamin D rather than calcitriol because it reflects your body's stored supply over the past two to three weeks.

The test captures both D2 (ergocalciferol, from plant sources) and D3 (cholecalciferol, from animal sources and sun exposure). Most modern immunoassays and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods report a combined total 1. LC-MS/MS is considered the gold standard because it distinguishes D2 from D3 and avoids cross-reactivity with other metabolites. If your lab report separates D2 and D3 values, add them together for the clinically meaningful total.

The half-life of 25-OH vitamin D in circulation is roughly 15 days 2. A single blood draw gives you a snapshot of your average vitamin D intake and production over the preceding two to three weeks. Seasonal variation is real: levels tend to peak in late summer and drop 10 to 20 ng/mL by late winter in northern latitudes, according to data from NHANES surveys 3.

Normal Ranges: Two Major Standards and Where You Fall

Two authoritative bodies set the reference ranges most U.S. labs use, and they disagree. That disagreement confuses patients.

The Institute of Medicine (IOM, now the National Academies) published its landmark 2011 report concluding that a 25-OH vitamin D level of 20 ng/mL (50 nmol/L) meets the needs of 97.5% of the general population for bone health 4. The IOM panel wrote: "A serum 25(OH)D level of 20 ng/mL covers the requirement of at least 97.5% of the population" and deliberately set a conservative threshold tied to skeletal outcomes.

The Endocrine Society's 2011 Clinical Practice Guideline, authored by Holick et al., set a higher bar. It defines deficiency as below 20 ng/mL, insufficiency as 21 to 29 ng/mL, and sufficiency as 30 ng/mL or above, with a preferred range of 40 to 60 ng/mL for patients at risk of deficiency 5. The Endocrine Society guideline states: "We suggest that all adults who are vitamin D deficient be treated with 50 to 000 IU of vitamin D2 or vitamin D3 once a week for 8 weeks... to achieve a blood level of 25(OH)D above 30 ng/mL."

Here is how to read your number against both frameworks:

| 25-OH Vitamin D Level | IOM Interpretation | Endocrine Society Interpretation | |---|---|---| | <12 ng/mL | Severely deficient | Severely deficient | | 12 to 19 ng/mL | Potentially inadequate | Deficient | | 20 to 29 ng/mL | Adequate | Insufficient | | 30 to 50 ng/mL | Adequate | Sufficient | | 40 to 60 ng/mL | Adequate | Preferred target (at-risk groups) | | >100 ng/mL | Potential concern | Upper safety limit | | >150 ng/mL | Risk of toxicity | Toxicity range |

Which standard your clinician follows depends on your risk profile. The IOM framework applies well to the general healthy population. The Endocrine Society ranges are more useful for patients with obesity, malabsorption, chronic kidney disease, or other conditions that impair vitamin D metabolism 5.

What a Low Result Means

A 25-OH vitamin D level below 20 ng/mL is deficient by any major guideline. This is common. Forrest and Stuhldreher (2011) analyzed NHANES data and found that 41.6% of U.S. adults had levels below 20 ng/mL, with prevalence reaching 82.1% among non-Hispanic Blacks and 69.2% among Hispanics 6.

Deficiency drives real clinical consequences. The best-documented effect is impaired calcium absorption, which leads to secondary hyperparathyroidism, bone loss, and increased fracture risk. Below 10 ng/mL, adults may develop osteomalacia (softened bones), presenting as diffuse bone pain and proximal muscle weakness 5.

Beyond bone, low vitamin D has been associated with higher risks of cardiovascular events, autoimmune conditions, depression, and all-cause mortality in observational studies 7. The causal picture is less clear. The VITAL trial (N=25,871) randomized healthy adults to 2 to 000 IU/day of vitamin D3 or placebo for a median of 5.3 years and found no significant reduction in invasive cancer or major cardiovascular events in the overall population 8. A secondary analysis, though, showed a 25% reduction in cancer death in the vitamin D group (HR 0.75 to 95% CI 0.59 to 0.96) 8.

Common causes of low levels include limited sun exposure, darker skin pigmentation, obesity (vitamin D is sequestered in adipose tissue), malabsorption syndromes (celiac disease, Crohn's disease, gastric bypass), chronic kidney disease, liver disease, and medications such as phenytoin, phenobarbital, and rifampin that accelerate vitamin D catabolism 5.

How to Raise a Low 25-OH Vitamin D Level

Correction depends on how low you are. The approach splits into two phases: loading and maintenance.

Loading phase for deficiency (below 20 ng/mL). The Endocrine Society recommends 50 to 000 IU of vitamin D2 or D3 once weekly for 8 weeks. In obese patients, those on anticonvulsants, or patients with malabsorption, the guideline suggests two to three times the standard dose 5. A meta-analysis by Autier et al. (2012) confirmed that D3 supplementation raises serum levels more effectively than D2 at equivalent doses 9.

Maintenance phase. After repletion, most adults need 1,500 to 2 to 000 IU daily to stay above 30 ng/mL. The Endocrine Society sets the tolerable upper intake at 10 to 000 IU/day for adults, while the IOM is more conservative at 4 to 000 IU/day 4 5.

Practical tips that affect absorption:

• Take vitamin D with a fat-containing meal. A study by Mulligan and Licata (2010) showed a 50% increase in absorption when vitamin D was taken with the largest meal compared to on an empty stomach 10.
• D3 (cholecalciferol) is preferred over D2 (ergocalciferol) for most patients. A randomized trial by Tripkovic et al. (2012) demonstrated that D3 is approximately 87% more potent in raising and maintaining 25-OH vitamin D concentrations 11.
• Magnesium supports vitamin D metabolism. Patients who are magnesium-depleted may respond poorly to supplementation alone 12.

Sun exposure can raise levels, but the dose is unpredictable. Approximately 10 to 15 minutes of midday sun on exposed arms and legs produces roughly 3 to 000 IU of D3 in fair-skinned individuals, but melanin, sunscreen (SPF 30 reduces synthesis by >95%), latitude above 35 degrees north from November through February, and aging all reduce cutaneous production 5.

Food sources alone are usually insufficient. An 8-ounce glass of fortified milk provides about 100 IU, and a 3.5-ounce serving of wild salmon provides 600 to 1 to 000 IU 5. Getting to 2 to 000 IU/day from food alone requires deliberate planning.

What a High 25-OH Vitamin D Mean

Levels above 100 ng/mL (250 nmol/L) warrant attention. True vitamin D toxicity, marked by hypercalcemia, typically occurs above 150 ng/mL and almost always results from supplement overuse rather than sun exposure or diet 13.

Symptoms of toxicity include nausea, vomiting, poor appetite, constipation, weakness, confusion, and polyuria. The mechanism is straightforward: excess calcitriol increases intestinal calcium absorption and bone resorption, pushing serum calcium above 10.5 mg/dL. Sustained hypercalcemia can cause nephrocalcinosis, renal stones, and cardiac arrhythmias 13.

A level between 60 and 100 ng/mL without hypercalcemia is not dangerous in isolation. Some patients on high-dose protocols (such as those with malabsorption) run in this range intentionally. The key clinical question is not just the 25-OH vitamin D number but whether serum calcium and intact PTH are normal 5. If your result exceeds 80 ng/mL and you are not under medical supervision for a known deficiency state, discuss dose reduction with your provider.

Granulomatous diseases (sarcoidosis, tuberculosis, some lymphomas) can produce elevated 25-OH vitamin D through extra-renal 1-alpha-hydroxylase activity in macrophages 14. In these cases, the active 1,25-dihydroxyvitamin D level is more clinically relevant than the 25-OH value.

How to Lower an Elevated 25-OH Vitamin D Level

Stop all vitamin D supplements immediately. That is the first step.

Because the half-life of 25-OH vitamin D is two to three weeks, levels will decline gradually over one to three months after discontinuation 2. Recheck the level at 8 to 12 weeks. Most cases of elevated 25-OH vitamin D resolve with supplement cessation alone.

If hypercalcemia is present (serum calcium >10.5 mg/dL), management becomes more urgent. Intravenous normal saline for volume expansion, loop diuretics (furosemide) to promote calciuresis, and glucocorticoids (prednisone 20 to 40 mg/day) to reduce intestinal calcium absorption are standard interventions 13. Severe cases with calcium above 14 mg/dL may require calcitonin or bisphosphonate therapy. This is a medical emergency that requires inpatient management.

For patients with granulomatous disease-associated hypervitaminosis D, glucocorticoids are the treatment of choice because they inhibit the macrophage 1-alpha-hydroxylase driving the excess production 14.

Reducing dietary calcium intake and avoiding calcium-fortified foods during the washout period is also reasonable, though the primary intervention remains stopping the supplement 13.

Who Should Get Tested

The Endocrine Society recommends screening only individuals at risk for deficiency, not the general population 5. The USPSTF found insufficient evidence to recommend screening in asymptomatic adults without risk factors 15.

Testing is appropriate for:

• Patients with osteoporosis, osteopenia, or fragility fractures
• Chronic kidney disease (stages 3 to 5)
• Malabsorption syndromes (celiac disease, inflammatory bowel disease, short bowel, gastric bypass)
• Obesity (BMI >30), since adipose tissue sequesters vitamin D
• Older adults with fall history or limited mobility
• Patients on medications that affect vitamin D metabolism (glucocorticoids, antiepileptics, antiretrovirals)
• Dark-skinned individuals living at higher latitudes
• Pregnant and lactating women (ACOG recommends considering screening) 16
• Hyperparathyroidism workup
• Patients with unexplained hypercalcemia

If you have none of these risk factors and your provider ordered the test as part of a wellness panel, a result between 20 and 50 ng/mL is reassuring and does not require follow-up testing 4.

When to Retest and What to Expect

After starting or adjusting supplementation, recheck 25-OH vitamin D at 8 to 12 weeks. That interval allows roughly three to four half-lives to pass, meaning your new steady-state level will be reflected. Testing earlier wastes money and creates confusing interim numbers.

As a rule of thumb, every 1 to 000 IU/day of vitamin D3 raises serum 25-OH vitamin D by approximately 6 to 10 ng/mL, though the response varies by body weight, baseline level, and absorption capacity 5. Obese patients often require 2 to 3 times the standard dose to achieve the same increment 17.

Once you reach your target range and stabilize on a maintenance dose, annual monitoring is usually sufficient. Patients with malabsorption, bariatric surgery, or chronic kidney disease may need testing every 6 months 5.

Seasonal timing matters. A level drawn in August may look adequate, but the same patient could drop below 20 ng/mL by February. If you live above the 35th parallel (roughly north of Atlanta or Los Angeles), consider a winter recheck during your first year of supplementation to confirm dose adequacy during the low-synthesis months 3.

Converting Between Units

U.S. labs typically report 25-OH vitamin D in ng/mL. International and many European labs use nmol/L. The conversion factor is 2.496: multiply ng/mL by 2.5 to get nmol/L, or divide nmol/L by 2.5 to get ng/mL.

| ng/mL | nmol/L | Status | |---|---|---| | <12 | <30 | Severe deficiency | | 12 to 19 | 30 to 49 | Deficiency | | 20 to 29 | 50 to 72 | Insufficiency (Endocrine Society) | | 30 to 100 | 75 to 250 | Sufficiency | | >150 | >375 | Toxicity risk |

If your lab report uses nmol/L and your clinician discusses targets in ng/mL, double-check the units before adjusting your dose. Confusion between these two scales is one of the most common sources of dosing errors in clinical practice.

The Endocrine Society target of 40 to 60 ng/mL translates to 100 to 150 nmol/L. At 2 to 000 IU/day of D3, most adults without malabsorption will land within the 30 to 50 ng/mL (75 to 125 nmol/L) range at steady state 5.